Intrinsic value of Select Medical Holdings - SEM

Previous Close

$19.45

  Intrinsic Value

$27.76

stock screener

  Rating & Target

buy

+43%

Previous close

$19.45

 
Intrinsic value

$27.76

 
Up/down potential

+43%

 
Rating

buy

We calculate the intrinsic value of SEM stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  3.70
  3.83
  3.95
  4.05
  4.15
  4.23
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.63
  4.67
  4.70
  4.73
  4.76
  4.78
  4.80
  4.82
  4.84
  4.86
  4.87
  4.88
  4.90
  4.91
  4.92
  4.92
  4.93
  4.94
Revenue, $m
  4,608
  4,785
  4,974
  5,175
  5,390
  5,618
  5,860
  6,117
  6,388
  6,676
  6,979
  7,300
  7,638
  7,994
  8,370
  8,767
  9,184
  9,623
  10,085
  10,572
  11,084
  11,622
  12,188
  12,784
  13,410
  14,068
  14,759
  15,486
  16,250
  17,052
Variable operating expenses, $m
  2,956
  3,058
  3,166
  3,282
  3,405
  3,536
  3,675
  3,822
  3,978
  4,143
  4,006
  4,190
  4,384
  4,589
  4,805
  5,032
  5,272
  5,524
  5,789
  6,069
  6,363
  6,672
  6,997
  7,338
  7,698
  8,075
  8,472
  8,890
  9,328
  9,789
Fixed operating expenses, $m
  1,281
  1,309
  1,338
  1,367
  1,397
  1,428
  1,459
  1,491
  1,524
  1,558
  1,592
  1,627
  1,663
  1,699
  1,737
  1,775
  1,814
  1,854
  1,895
  1,936
  1,979
  2,022
  2,067
  2,112
  2,159
  2,206
  2,255
  2,304
  2,355
  2,407
Total operating expenses, $m
  4,237
  4,367
  4,504
  4,649
  4,802
  4,964
  5,134
  5,313
  5,502
  5,701
  5,598
  5,817
  6,047
  6,288
  6,542
  6,807
  7,086
  7,378
  7,684
  8,005
  8,342
  8,694
  9,064
  9,450
  9,857
  10,281
  10,727
  11,194
  11,683
  12,196
Operating income, $m
  372
  419
  470
  527
  588
  654
  726
  803
  886
  975
  1,381
  1,482
  1,591
  1,706
  1,829
  1,959
  2,098
  2,245
  2,401
  2,567
  2,742
  2,928
  3,125
  3,333
  3,553
  3,786
  4,032
  4,292
  4,567
  4,857
EBITDA, $m
  1,098
  1,161
  1,229
  1,304
  1,385
  1,472
  1,565
  1,665
  1,773
  1,887
  2,010
  2,140
  2,279
  2,426
  2,583
  2,749
  2,925
  3,112
  3,310
  3,519
  3,741
  3,975
  4,223
  4,485
  4,761
  5,053
  5,362
  5,687
  6,031
  6,393
Interest expense (income), $m
  143
  156
  164
  174
  185
  196
  208
  220
  233
  248
  263
  278
  295
  313
  332
  351
  372
  394
  417
  441
  467
  493
  522
  551
  583
  615
  650
  686
  724
  764
  807
Earnings before tax, $m
  216
  254
  296
  342
  392
  447
  506
  570
  639
  712
  1,102
  1,187
  1,278
  1,375
  1,478
  1,587
  1,704
  1,828
  1,960
  2,100
  2,249
  2,407
  2,574
  2,750
  2,938
  3,136
  3,346
  3,568
  3,802
  4,050
Tax expense, $m
  58
  69
  80
  92
  106
  121
  137
  154
  172
  192
  298
  321
  345
  371
  399
  429
  460
  494
  529
  567
  607
  650
  695
  743
  793
  847
  903
  963
  1,027
  1,094
Net income, $m
  158
  186
  216
  250
  286
  326
  369
  416
  466
  520
  805
  867
  933
  1,003
  1,079
  1,159
  1,244
  1,335
  1,431
  1,533
  1,642
  1,757
  1,879
  2,008
  2,145
  2,289
  2,442
  2,604
  2,776
  2,957

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  5,315
  5,519
  5,737
  5,969
  6,217
  6,480
  6,759
  7,055
  7,368
  7,700
  8,050
  8,419
  8,809
  9,221
  9,654
  10,111
  10,593
  11,099
  11,632
  12,194
  12,784
  13,405
  14,058
  14,745
  15,467
  16,226
  17,023
  17,862
  18,743
  19,668
Adjusted assets (=assets-cash), $m
  5,315
  5,519
  5,737
  5,969
  6,217
  6,480
  6,759
  7,055
  7,368
  7,700
  8,050
  8,419
  8,809
  9,221
  9,654
  10,111
  10,593
  11,099
  11,632
  12,194
  12,784
  13,405
  14,058
  14,745
  15,467
  16,226
  17,023
  17,862
  18,743
  19,668
Revenue / Adjusted assets
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
Average production assets, $m
  4,152
  4,311
  4,481
  4,663
  4,856
  5,062
  5,280
  5,511
  5,756
  6,015
  6,288
  6,577
  6,882
  7,203
  7,542
  7,899
  8,275
  8,670
  9,087
  9,525
  9,987
  10,472
  10,982
  11,518
  12,082
  12,675
  13,298
  13,953
  14,641
  15,364
Working capital, $m
  -134
  -139
  -144
  -150
  -156
  -163
  -170
  -177
  -185
  -194
  -202
  -212
  -221
  -232
  -243
  -254
  -266
  -279
  -292
  -307
  -321
  -337
  -353
  -371
  -389
  -408
  -428
  -449
  -471
  -495
Total debt, $m
  2,885
  3,056
  3,238
  3,433
  3,641
  3,862
  4,096
  4,344
  4,607
  4,885
  5,179
  5,489
  5,816
  6,161
  6,525
  6,909
  7,312
  7,737
  8,185
  8,656
  9,151
  9,672
  10,220
  10,796
  11,402
  12,039
  12,708
  13,411
  14,150
  14,927
Total liabilities, $m
  4,460
  4,630
  4,813
  5,008
  5,216
  5,437
  5,671
  5,919
  6,182
  6,460
  6,754
  7,064
  7,391
  7,736
  8,100
  8,483
  8,887
  9,312
  9,760
  10,230
  10,726
  11,247
  11,795
  12,371
  12,977
  13,613
  14,283
  14,986
  15,725
  16,502
Total equity, $m
  856
  889
  924
  961
  1,001
  1,043
  1,088
  1,136
  1,186
  1,240
  1,296
  1,356
  1,418
  1,485
  1,554
  1,628
  1,705
  1,787
  1,873
  1,963
  2,058
  2,158
  2,263
  2,374
  2,490
  2,612
  2,741
  2,876
  3,018
  3,167
Total liabilities and equity, $m
  5,316
  5,519
  5,737
  5,969
  6,217
  6,480
  6,759
  7,055
  7,368
  7,700
  8,050
  8,420
  8,809
  9,221
  9,654
  10,111
  10,592
  11,099
  11,633
  12,193
  12,784
  13,405
  14,058
  14,745
  15,467
  16,225
  17,024
  17,862
  18,743
  19,669
Debt-to-equity ratio
  3.370
  3.440
  3.510
  3.570
  3.640
  3.700
  3.760
  3.820
  3.880
  3.940
  4.000
  4.050
  4.100
  4.150
  4.200
  4.240
  4.290
  4.330
  4.370
  4.410
  4.450
  4.480
  4.520
  4.550
  4.580
  4.610
  4.640
  4.660
  4.690
  4.710
Adjusted equity ratio
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  158
  186
  216
  250
  286
  326
  369
  416
  466
  520
  805
  867
  933
  1,003
  1,079
  1,159
  1,244
  1,335
  1,431
  1,533
  1,642
  1,757
  1,879
  2,008
  2,145
  2,289
  2,442
  2,604
  2,776
  2,957
Depreciation, amort., depletion, $m
  726
  742
  759
  777
  797
  817
  839
  862
  886
  912
  629
  658
  688
  720
  754
  790
  827
  867
  909
  953
  999
  1,047
  1,098
  1,152
  1,208
  1,268
  1,330
  1,395
  1,464
  1,536
Funds from operations, $m
  884
  928
  975
  1,027
  1,083
  1,143
  1,208
  1,278
  1,353
  1,432
  1,434
  1,524
  1,621
  1,724
  1,833
  1,949
  2,072
  2,202
  2,340
  2,486
  2,640
  2,804
  2,977
  3,160
  3,353
  3,557
  3,772
  4,000
  4,240
  4,493
Change in working capital, $m
  -5
  -5
  -5
  -6
  -6
  -7
  -7
  -7
  -8
  -8
  -9
  -9
  -10
  -10
  -11
  -11
  -12
  -13
  -13
  -14
  -15
  -16
  -16
  -17
  -18
  -19
  -20
  -21
  -22
  -23
Cash from operations, $m
  889
  933
  981
  1,033
  1,089
  1,150
  1,215
  1,285
  1,361
  1,441
  1,442
  1,534
  1,631
  1,734
  1,844
  1,960
  2,084
  2,214
  2,353
  2,500
  2,655
  2,820
  2,993
  3,177
  3,371
  3,576
  3,792
  4,021
  4,262
  4,516
Maintenance CAPEX, $m
  -400
  -415
  -431
  -448
  -466
  -486
  -506
  -528
  -551
  -576
  -601
  -629
  -658
  -688
  -720
  -754
  -790
  -827
  -867
  -909
  -953
  -999
  -1,047
  -1,098
  -1,152
  -1,208
  -1,268
  -1,330
  -1,395
  -1,464
New CAPEX, $m
  -149
  -159
  -170
  -182
  -193
  -206
  -218
  -231
  -245
  -259
  -273
  -289
  -305
  -321
  -339
  -357
  -376
  -396
  -417
  -438
  -461
  -485
  -510
  -536
  -564
  -593
  -623
  -655
  -688
  -723
Cash from investing activities, $m
  -549
  -574
  -601
  -630
  -659
  -692
  -724
  -759
  -796
  -835
  -874
  -918
  -963
  -1,009
  -1,059
  -1,111
  -1,166
  -1,223
  -1,284
  -1,347
  -1,414
  -1,484
  -1,557
  -1,634
  -1,716
  -1,801
  -1,891
  -1,985
  -2,083
  -2,187
Free cash flow, $m
  339
  358
  379
  403
  429
  459
  491
  526
  565
  606
  567
  616
  668
  725
  785
  849
  918
  991
  1,070
  1,153
  1,242
  1,336
  1,436
  1,542
  1,655
  1,775
  1,902
  2,036
  2,178
  2,329
Issuance/(repayment) of debt, $m
  155
  171
  183
  195
  208
  221
  234
  248
  263
  278
  294
  310
  327
  345
  364
  383
  404
  425
  447
  471
  495
  521
  548
  576
  606
  637
  669
  703
  739
  777
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  155
  171
  183
  195
  208
  221
  234
  248
  263
  278
  294
  310
  327
  345
  364
  383
  404
  425
  447
  471
  495
  521
  548
  576
  606
  637
  669
  703
  739
  777
Total cash flow (excl. dividends), $m
  494
  529
  562
  598
  637
  680
  725
  775
  828
  884
  861
  926
  996
  1,070
  1,148
  1,232
  1,322
  1,416
  1,517
  1,624
  1,737
  1,857
  1,984
  2,118
  2,261
  2,412
  2,571
  2,739
  2,917
  3,106
Retained Cash Flow (-), $m
  -33
  -33
  -35
  -37
  -40
  -42
  -45
  -48
  -50
  -53
  -56
  -60
  -63
  -66
  -70
  -74
  -77
  -82
  -86
  -90
  -95
  -100
  -105
  -111
  -116
  -122
  -128
  -135
  -142
  -149
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  18
  18
  19
  20
  21
  22
  22
  23
  24
  26
  27
  28
  29
  31
  32
  33
  35
  37
  38
  40
  42
  44
  46
  49
  51
  54
  56
  59
  62
  65
Cash available for distribution, $m
  462
  496
  527
  561
  597
  637
  680
  727
  777
  831
  805
  867
  933
  1,003
  1,079
  1,159
  1,244
  1,335
  1,431
  1,533
  1,642
  1,757
  1,879
  2,008
  2,145
  2,289
  2,442
  2,604
  2,776
  2,957
Discount rate, %
  11.10
  11.66
  12.24
  12.85
  13.49
  14.17
  14.88
  15.62
  16.40
  17.22
  18.08
  18.98
  19.93
  20.93
  21.98
  23.08
  24.23
  25.44
  26.71
  28.05
  29.45
  30.92
  32.47
  34.09
  35.80
  37.59
  39.47
  41.44
  43.51
  45.69
PV of cash for distribution, $m
  415
  398
  373
  346
  317
  288
  258
  228
  198
  170
  129
  108
  88
  70
  55
  42
  31
  23
  16
  11
  7
  5
  3
  2
  1
  1
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company's segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.

FINANCIAL RATIOS  of  Select Medical Holdings (SEM)

Valuation Ratios
P/E Ratio 22.4
Price to Sales 0.6
Price to Book 3.2
Price to Tangible Book
Price to Cash Flow 7.4
Price to Free Cash Flow 13.9
Growth Rates
Sales Growth Rate 14.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -11.5%
Cap. Spend. - 3 Yr. Gr. Rate 17%
Financial Strength
Quick Ratio 2
Current Ratio 0.1
LT Debt to Equity 329%
Total Debt to Equity 335.5%
Interest Coverage 2
Management Effectiveness
Return On Assets 4.6%
Ret/ On Assets - 3 Yr. Avg. 5.3%
Return On Total Capital 3.4%
Ret/ On T. Cap. - 3 Yr. Avg. 4.5%
Return On Equity 13.7%
Return On Equity - 3 Yr. Avg. 15.3%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 14.5%
Gross Margin - 3 Yr. Avg. 14.8%
EBITDA Margin 10.9%
EBITDA Margin - 3 Yr. Avg. 11.2%
Operating Margin 6.7%
Oper. Margin - 3 Yr. Avg. 7.8%
Pre-Tax Margin 4.2%
Pre-Tax Margin - 3 Yr. Avg. 5.5%
Net Profit Margin 2.7%
Net Profit Margin - 3 Yr. Avg. 3.4%
Effective Tax Rate 30.9%
Eff/ Tax Rate - 3 Yr. Avg. 34.3%
Payout Ratio 0%

SEM stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SEM stock intrinsic value calculation we used $4444 million for the last fiscal year's total revenue generated by Select Medical Holdings. The default revenue input number comes from 2017 income statement of Select Medical Holdings. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SEM stock valuation model: a) initial revenue growth rate of 3.7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 11.1%, whose default value for SEM is calculated based on our internal credit rating of Select Medical Holdings, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Select Medical Holdings.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SEM stock the variable cost ratio is equal to 64.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1253 million in the base year in the intrinsic value calculation for SEM stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.7% for Select Medical Holdings.

Corporate tax rate of 27% is the nominal tax rate for Select Medical Holdings. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SEM stock is equal to 0.4%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SEM are equal to 90.1%.

Life of production assets of 10 years is the average useful life of capital assets used in Select Medical Holdings operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SEM is equal to -2.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $823 million for Select Medical Holdings - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 129 million for Select Medical Holdings is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Select Medical Holdings at the current share price and the inputted number of shares is $2.5 billion.

RELATED COMPANIES Price Int.Val. Rating
USPH U.S. Physical 104.60 92.03  hold
THC Tenet Healthca 35.11 17.17  sell
MYOK MyoKardia 56.80 4.12  str.sell

COMPANY NEWS

▶ Select Medical: 1Q Earnings Snapshot   [05:04AM  Associated Press]
▶ Select Medical beats 4Q profit forecasts   [Feb-21-18 06:03PM  Associated Press]
▶ Stocks Generating Improved Relative Strength: Select Medical   [Jan-05-18 03:00AM  Investor's Business Daily]
▶ Select Medical Sees Relative Strength Rating Climb To 74   [03:00AM  Investor's Business Daily]
▶ Select Medical Clears Key Benchmark, Hitting 80-Plus RS Rating   [Dec-07-17 03:00AM  Investor's Business Daily]
▶ Stocks With Rising Relative Price Strength: Select Medical   [Nov-30-17 03:00AM  Investor's Business Daily]
▶ Select Medical misses 3Q profit forecasts   [05:39AM  Associated Press]
▶ Select Medical beats 2Q profit forecasts   [Aug-05-17 01:13AM  Associated Press]
▶ The 3 Best Hospital Stocks to Buy in 2017   [May-17-17 04:42PM  Motley Fool]
▶ Select Medical beats 1Q profit forecasts   [May-05-17 05:03AM  Associated Press]
▶ Top Ranked Value Stocks to Buy for April 19th   [Apr-19-17 07:52AM  Zacks]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.